ArticleWorld journal of gastroenterology2019

Change in arterial tumor perfusion is an early biomarker of lenvatinib efficacy in patients with unresectable hepatocellular carcinoma.

Hidekatsu Kuorda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.